학술논문
GULLIVER-2 IS AN INNOVATIVE, HYBRID, HEPATIC IMPAIRMENT TRIAL OF THE ORAL GALECTIN-3 INHIBITOR GB1211
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15273350